{
    "2021-05-25": [
        [
            {
                "time": "2021-06-03",
                "original_text": "AbbVie Showcases the Depth of its Rheumatology Portfolio with New Data Presented at the EULAR 2021 Virtual Congress of Rheumatology",
                "features": {
                    "keywords": [
                        "AbbVie",
                        "Rheumatology",
                        "Portfolio",
                        "New Data",
                        "EULAR"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2021-06-04",
                "original_text": "AbbVie Receives European Commission Approval of VENCLYXTOÂ® (venetoclax) in Combination with a Hypomethylating Agent for Patients with Newly Diagnosed Acute Myeloid Leukemia Who Are Ineligible for Intensive Chemotherapy",
                "features": {
                    "keywords": [
                        "AbbVie",
                        "European Commission",
                        "VENCLYXTO",
                        "Approval",
                        "Acute Myeloid Leukemia"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2021-06-05",
                "original_text": "2 High-Yield Dividend Stocks for 2021",
                "features": {
                    "keywords": [
                        "High-Yield",
                        "Dividend",
                        "Stocks",
                        "2021"
                    ],
                    "sentiment_score": 0.65,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "finance",
                        "investing"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-06-06",
                "original_text": "3 Strong Stocks for Your Income Tax Return",
                "features": {
                    "keywords": [
                        "Strong Stocks",
                        "Income Tax",
                        "Return"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "finance",
                        "investing"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}